NEW YORK — Proteomics start-up Seer said today it has closed a $55 million funding round led by Fidelity Management and Research Company.
The firm said that it plans to use the funds to expand its research and development work and to prepare for the 2021 commercial launch of its proteomics system, called Proteograph.